382 related articles for article (PubMed ID: 10848059)
41. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
42. [Immuno-allergic accidents with rifamipcin].
Flageul B; Wagner L; Cottenot F
Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
Reyes-Javier PD; Tantiongco PR
Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
[No Abstract] [Full Text] [Related]
44. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
Kumar B; Kaur S; Kaur I
Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
[TBL] [Abstract][Full Text] [Related]
45. Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy.
Ravanes JM; Cellona RV; Balagon M; Abalos RM; Walsh GP; Walsh DS
Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):323-30. PubMed ID: 21710853
[TBL] [Abstract][Full Text] [Related]
46. Clinical trial with clofazimine in leprosy.
Ganapati R; Dongre VV
Lepr India; 1976 Oct; 48(4 Suppl):703-8. PubMed ID: 1026807
[TBL] [Abstract][Full Text] [Related]
47. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
Martinez Cruz D
Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
[No Abstract] [Full Text] [Related]
48. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
[TBL] [Abstract][Full Text] [Related]
49. Influence of acetylator phenotype on the haematological and biochemical effects associated with dapsone in leprosy patients.
Queiroz RH; Souza AM; Melchior E; Gouveia EG; Carvalho D
Lepr Rev; 1997 Sep; 68(3):212-7. PubMed ID: 9364821
[TBL] [Abstract][Full Text] [Related]
50. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
Winsley BE; McDougall AC; Brown KE
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
[No Abstract] [Full Text] [Related]
51. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
Mehta J; Gandhi IS; Sane SB; Wamburkar MN
Indian J Lepr; 1985; 57(2):297-310. PubMed ID: 4078356
[TBL] [Abstract][Full Text] [Related]
52. Treatment of leprosy.
Kar HK; Gupta R
Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
[TBL] [Abstract][Full Text] [Related]
53. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.
Kroger A; Pannikar V; Htoon MT; Jamesh A; Katoch K; Krishnamurthy P; Ramalingam K; Jianping S; Jadhav V; Gupte MD; Manickam P
Trop Med Int Health; 2008 May; 13(5):594-602. PubMed ID: 18346026
[TBL] [Abstract][Full Text] [Related]
54. Chemotherapy of leprosy.
Biswas SK;
J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354
[TBL] [Abstract][Full Text] [Related]
55. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
Pattyn S; Grillone S
Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
[TBL] [Abstract][Full Text] [Related]
56. Multi-drug therapy in leprosy: an effective method of control.
Indian J Lepr; 1984; 56(1):102-12. PubMed ID: 6548238
[TBL] [Abstract][Full Text] [Related]
57. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
Singh RP; Tiwari VD; Chattopadhyay SP
Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
[TBL] [Abstract][Full Text] [Related]
58. Three years assessment of multidrug therapy in multibacillary leprosy cases.
Ganapati R; Revankar CR; Pai RR
Indian J Lepr; 1987; 59(1):44-9. PubMed ID: 3611860
[TBL] [Abstract][Full Text] [Related]
59. Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients.
Cruz RCDS; Bührer-Sékula S; Penna MLF; Penna GO; Talhari S
An Bras Dermatol; 2017; 92(6):761-773. PubMed ID: 29364430
[TBL] [Abstract][Full Text] [Related]
60. A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
Ganapati R; Pai VV; Banerji U; Thomas J; Saha B
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):495-7. PubMed ID: 9465161
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
